The SISAQOL-IMI consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), just published its pivotal paper in The Lancet Oncology ...
The Wall Street Transcript is a completely unique resource for investors and business researchers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results